IAP/APA evidence-based guidelines for the management of acute pancreatitis Flashcards

https://www.sciencedirect.com/science/article/pii/S1424390313005255?via%3Dihub

1
Q

What is the definition of acute pancreatitis (regardless of etiology)?

A

The definition of acute pancreatitis is based on the fulfillment of ‘2 out of 3’ of the following criteria: clinical (upper abdominal pain), laboratory (serum amylase or lipase >3 upper limit of normal) and/or imaging (computed tomography, magnetic resonance (MR), ultrasonography) criteria. (GRADE 1B, strong agreement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

On admission, what should be done to determine the etiology of acute pancreatitis?

A

On admission, the etiology of acute pancreatitis should be determined using detailed personal (i.e. previous acute pancreatitis, known gallstone disease, alcohol intake, medication and drug intake, known hyperlipidemia, trauma, recent invasive procedures such as endoscopic retrograde cholangiopancreatography (ERCP)) and family history of pancreatic disease, physical examination, laboratory serum tests (i.e. liver enzymes, calcium, triglycerides), and imaging (i.e. right upper quadrant ultrasonography). (GRADE 1B, strong agreement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What further investigations are indicated in patients after a first or second attack of idiopathic acute pancreatitis?

A

In patients considered to have idiopathic acute pancreatitis, after negative routine work-up for biliary etiology (e.g. repeated right upper quadrant ultrasonography), endoscopic ultrasonography (EUS) is recommended as the first step to assess for occult microlithiasis, neoplasms and chronic pancreatitis. If EUS is negative, (secretin-stimulated) magnetic resonance chol- angiopancreatography (MRCP) is advised as a second step to identify rare morphologic abnormalities. CT of the abdomen should be performed (i.e. if not performed before). If etiology remains unidentified, especially after a second attack of idiopathic pancreatitis, genetic counseling (not necessarily genetic testing) should be considered.(GRADE 2C, weak agreement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the best score/marker (including cut-off value) to predict severe acute pancreatitis on admission and at 48 h?

A

Systemic inflammatory response syndrome (SIRS) is advised to predict severe acute pancreatitis at admission and persistent SIRS at 48 h. (GRADE 2B, weak agreement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the best strategy to predict outcome of acute
pancreatitis during admission?

A

During admission, a 3-dimension approach is advised to predict outcome of acute pancreatitis combining

  • host risk factors (e.g. age, co-morbidity, body mass index)
  • clinical risk stratification (e.g. persistent SIRS)
  • monitoring response to initial therapy (e.g. persistent SIRS, blood urea nitrogen, creatinine)

(GRADE 2B, strong agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the indication for and timing of the initial CT
assessment in acute pancreatitis?

A

The indication for initial CT assessment in acute pancreatitis can be:

(1) diagnostic uncertainty,
(2) confirmation of severity based on clinical predictors of severe acute pancreatitis, or
(3) failure to respond to conservative treatment or in the setting of clinical deterioration.

Optimal timing for initial CT assessment is at least 72-96 h after onset of symptoms.
(GRADE 1C, strong agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the indication for follow-up scanning (CT/MR)?

A

Follow-up CT or MR in acute pancreatitis is indicated when there is a lack of clinical improvement, clinical deterioration, or especially when invasive intervention is considered.
(GRADE 1C, strong agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the optimal CT and MR protocol to detect
necrosis?

A

It is recommended to perform multidetector CT with thin collimation and slice thickness (i.e. 5 mm or less), 100e150 ml of non-ionic intravenous contrast material at a rate of 3 ml/s, during the pancreatic and/or portal venous phase (i.e. 50e70 s delay). During follow-up only a portal venous phase (mono-phasic) is generally sufficient. For MR, the recommendation is to perform axial FS-T2 and FS-T1 scanning before and after intravenous gadolinium contrast administration.
(GRADE 1C, strong agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the best fluid to use for initial fluid resuscitation
in acute pancreatitis?

A

Ringer’s lactate is recommended for initial fluid resuscitation in acute pancreatitis.
(GRADE 1B, strong agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the optimal fluid infusion rate and response
measurement for initial fluid resuscitation?

A

Optimal infusion rate for initial fluid resuscitation: goal directedintravenousfluid therapywith 5e10ml/kg/h should be used initially until resuscitation goals are reached. (GRADE 1B, weak agreement).

Measuring the response to fluid resuscitation: the preferred approach to assessing the response tofluid resuscitation should be based on one or more of the following:

(1) non-invasive clinical targets of heart rate <120/min, mean arterial pressure between 65 and 85 mmHg (8.7e11.3 kPa), and urinary output >0.5e1 ml/kg/h,
(2) invasive clinical targets of stroke volume variation, and intrathoracic blood volume determination,

(3) biochemical targets of hematocrit 35-44%.
(GRADE 2B, weak agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the indications for admission to an intensive
care unit in acute pancreatitis?

A

A patient diagnosed with acute pancreatitis and one or more of the following parameters identified at admission as defined by the guidelines of the Society of Critical Care Medicine (SCCM) should be transferred immediately to an intensive care setting:

(1) pulse <40 or >150 beats/min
(2) systolic arterial pressure <80 mmHg (<10.7 kPa) or mean arterial pressure <60 mmHg or diastolic arterial pressure >120 mmHg
(3) respiratory rate >35 breaths/min
(4) serum sodium <110 mmol/l or >170 mmol/l
(5) serum potassium <2.0 mmol/l or >7.0 mmol/l
(6) paO2 <50 mmHg;
(7) pH < 7.1 or >7.7
8) serum glucose >800 mg/dl
(9) serum calcium > 15 mg/dl (>3.75 mmol/L)
(10) anuria
(11) coma.

Furthermore, a patient with severe acute pancreatitis as defined by the revised Atlanta Classification (i.e. persistent organ failure) should be treated in an intensive care setting.
(GRADE 1C, strong agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the indications for referral to a specialist
center?

A

Management in, or referral to, a specialist center is necessary for patients with severe acute pancreatitis and for those who may need interventional radiologic, endoscopic, or surgical intervention.
(GRADE 1C, strong agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the minimal requirements for a specialist
center?

A

A specialist center in the management of acute pancreatitis is defined as a high volume center with up-to-date intensive care facilities including options for organ replacement therapy, and with daily (i.e. 7 days per week) access to interventional radiology, interventional endoscopy with EUS and ERCP assistance as well as surgical expertise in managing necrotizing pancreatitis. Patients should be enrolled in prospective audits for quality control issues and into clinical trials whenever possible.

(GRADE 2C, weak agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Can persistent SIRS/organ failure be prevented?

A

Early fluid resuscitation within the first 24 h of admission for acute pancreatitis is associated with decreased rates of persistent SIRS and organ failure.

(GRADE 1C, strong agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the definition of abdominal compartment
syndrome?

A

Intra-abdominal pressure is the steady-state pressure within the abdominal cavity. Abdominal compartment syndrome (ACS) is defined as a sustained intra-abdominal pressure > 20 mmHg (with or without abdominal arterial perfusion pressure <60 mmHg) that is associated with new onset organ failure.
(GRADE 2B, strong agreement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How should ACS be treated?

A

Medical interventions for ACS in acute pancreatitis: interventions to decrease intra-abdominal pressure should target the most important contributors to IAH in acute pancreatitis:

1) Hollow-viscera volume: nasogastric drainage, prokinetics, rectal tubes, if necessary endoscopic decompression.
2) Intra/extra vascular fluid: volume resuscitation on demand, if volume overloaded either ultrafiltration or diuretics can be employed.
3) Abdominal wall expansion: adequate analgesia and sedation to decrease abdominal muscle tone, if necessary neuromuscular blockade.

Invasive treatment for ACS in acute pancreatitis: invasive decompression should only be used after multidisciplinary discussion in patients with a sustained intra-abdominal pressure >25 mmHg with new onset organ failure refractory to medical therapy and
nasogastric/rectal decompression. Invasive treatment options include percutaneous catheter drainage of ascites, midline laparostomy, bilateral subcostal laparostomy, or subcutaneous linea alba fasciotomy. In case of surgical decompression, the retroperitoneal cavity and the omental bursa should be left intact to reduce the risk of infecting peripancreatic and pancreatic necrosis.
(GRADE 2C, strong agreement).

17
Q

Is systemic antibiotic prophylaxis effective in preventing infectious complications in acute pancreatitis?

A

Intravenous antibiotic prophylaxis is not recommended for the prevention of infectious complications in acute pancreatitis.
(GRADE 1B, strong agreement).

18
Q

Is selective gut decontamination effective in preventing
infectious complications?

A

Selective gut decontamination has shown some benefits in preventing infectious complications in acute pancreatitis, but further studies are needed.
(GRADE 2B, weak agreement).

19
Q

Are probiotics effective in preventing infectious
complications?

A

Probiotic prophylaxis is not recommended for the prevention of infectious complications in acute pancreatitis.
(GRADE 1B, strong agreement).

20
Q

When should oral feeding be restarted in patients with
predicted mild pancreatitis?

A

Oral feeding in predicted mild pancreatitis can be restarted once abdominal pain is decreasing and inflammatory markers are improving.
(GRADE 2B, strong agreement).

21
Q

What is the indication for enteral tube feeding?

A

Enteral tube feeding should be the primary therapy in patients with predicted severe acute pancreatitis who require nutritional support.
(GRADE 1B, strong agreement).

22
Q

What type of enteral nutrition should be used?

A

Either elemental or polymeric enteral nutrition formulations can be used in acute pancreatitis.
(GRADE 2B, strong agreement).

23
Q

Should enteral nutrition be administered via a nasoje-
junal or nasogastric route?

A

Enteral nutrition in acute pancreatitis can be administered via either the nasojejunal or nasogastric route.
(GRADE 2A, strong agreement).

24
Q

What is the role of parenteral nutrition?

A

Parenteral nutrition can be administered in acute pancreatitis as second-line therapy if nasojejunal tube feeding is not tolerated and nutritional support is required.
(GRADE 2C, strong agreement).

25
Q

What is the indication for ERCP and sphincterotomy
early in the course of biliary pancreatitis?

A
  1. ERCP is not indicated in predicted mild biliary pancreatitis without cholangitis(GRADE 1A, strong agreement).
  2. ERCP is probably not indicated in predicted severe biliary pancreatitis without cholangitis (GRADE 1B, strong agreement).
  3. ERCP is probably indicated in biliary pancreatitis with common bile duct obstruction. (GRADE 1C, strong agreement).
  4. ERCP is indicated in patients with biliary pancreatitis and cholangitis (GRADE 1B, strong agreement).
26
Q

If indicated, what is the optimal timing for ERCP in
biliary pancreatitis?

A
Urgent ERCP (\<24 h) is required in patients with acute cholangitis. Currently, there is no evidence regarding the optimal timing of ERCP in patients with biliary pancreatitis without cholangitis.
(GRADE 2C, strong agreement).
27
Q

What is the role of MRCP and EUS in biliary pancreatitis?

A

MRCP and EUS may prevent a proportion of ERCPs that would otherwise be performed for suspected common bile duct stones in patients with biliary pancreatitis who do not have cholangitis, without influencing the clinical course. EUS is superior to MRCP in excluding the presence of small (<5 mm) gallstones. MRCP is less invasive, less operator-dependent and probably more widely available than EUS. Therefore, in clinical practice there is no clear superiority for either MRCP or EUS.
(GRADE 2C, strong agreement).

28
Q

What are the indications for intervention in necrotizing
pancreatitis?

A

Common indications for intervention (either radiological, endoscopical or surgical) in necrotizing pancreatitis are:

  • Clinical suspicion of, or documented, infected necrotizing pancreatitis with clinical deterioration, preferably when the necrosis has become walled-off.
  • In the absence of documented infected necrotizing pancreatitis, ongoing organ failure for several weeks after the onset of acute pancreatitis, preferably when the necrosis has become walled-off.

Less common indications for intervention are:

  • Abdominal compartment syndrome
  • Ongoing acute bleeding
  • Bowel ischemia
  • Ongoing gastric outlet, intestinal, or biliary obstruction due to

mass effect from large walled-off necrosis (arbitrarily >4-8 weeks after onset of pancreatitis)
(GRADE 1C, strong agreement).

29
Q

What is the role of fine needle aspiration to diagnose
infected necrotizing pancreatitis?

A

Routine percutaneous fine needle aspiration of peripancreatic collections to detect bacteria is not indicated, because clinical signs (i.e. persistent fever, increasing inflammatory markers) and imaging signs (i.e. gas in peripancreatic collections) are accurate predictors ofinfected necrosisin themajority of patients. Although the diagnosis of infection can be confirmed by fine needle aspiration (FNA), there is a risk of false-negative results.

(GRADE 1C, strong agreement).

30
Q

What are the indications for intervention in sterile
necrotizing pancreatitis?

A

Indications for intervention (either radiological, endoscopical or surgical) in sterile necrotizing pancreatitis are:

  • Ongoing gastric outlet, intestinal, or biliary obstruction due to mass effect of walled-off necrosis (i.e. arbitrarily >4-8 weeks after onset of acute pancreatitis).
  • Persistent symptoms (e.g. pain, ‘persistent unwellness’) in patients with walled-off necrosis without signs of infection (i.e. arbitrarily >8 weeks after onset of acute pancreatitis).
  • Disconnected duct syndrome (i.e. full transection of the pancreatic duct in the presence of pancreatic necrosis) with persisting symptomatic (e.g. pain, obstruction) collection(s) with necrosis without signs of infections (i.e. arbitrarily >8 weeks after onset of acute pancreatitis).

(GRADE 2C, strong agreement).

31
Q

What is the optimal timing of intervention for suspected
or confirmed infected necrosis?

A

For patients with proven or suspected infected necrotizing pancreatitis, invasive intervention (i.e. percutaneous catheter drainage, endoscopic transluminal drainage/necrosectomy, minimally invasive or open necrosectomy) should be delayed
where possible until at least 4 weeks after initial presentation to allow the collection to become ‘walled-off’.
(GRADE 1C, strong agreement).

32
Q

Can subgroups of patients with necrotizing pancreatitis
be defined that require early or late intervention?

A

The best available evidence suggests that surgical necrosectomy should ideally be delayed until collections have become walled-off, typically 4 weeks after the onset of pancreatitis, in all patients with complications of necrosis. No subgroups have been identified that might benefit from earlier or delayed intervention.
(GRADE 1C, strong agreement).

33
Q

What is the optimal interventional strategy (percuta-
neous catheter drainage, endoscopic transluminal drainage/necrosectomy, minimally invasive or open necrosectomy) for suspected or confirmed infected necrotizing pancreatitis?

A

The optimal interventional strategy for patients with suspected or confirmed infected necrotizing pancreatitis is initial image guided percutaneous (retroperitoneal) catheter drainage or endoscopic transluminal drainage, followed, if necessary, by endoscopic or surgical necrosectomy.
(GRADE 1A, strong agreement).

34
Q

Should catheter drainage (percutaneous or endoscopic
transluminal) always be the first step for suspected or
confirmed infected necrotizing pancreatitis?

A

Percutaneous catheter or endoscopic transmural drainage should be the first step in the treatment of patients with suspected or confirmed (walled-off) infected necrotizing pancreatitis.
(GRADE 1A, strong agreement).

35
Q

Can subgroups of patients with infected necrotizing
pancreatitis be defined who require different strategies
(including conservative treatment)?

A

There are insufficient data to define subgroups of patients with suspected or confirmed infected necrotizing pancreatitis who would benefit from a different treatment strategy.
(GRADE 2C, strong agreement).

36
Q

What is the optimal timing of cholecystectomy after
mild biliary pancreatitis?

A

Cholecystectomy during index admission for mild biliary pancreatitis appears safe and is recommended. Interval cholecystectomy after mild biliary pancreatitis is associated with a substantial risk of readmission for recurrent biliary events, especially recurrent biliary pancreatitis.
(GRADE 1C, strong agreement).

37
Q

What is the optimal timing of cholecystectomy after
severe biliary pancreatitis?

A

Cholecystectomy should be delayed in patients with peripancreatic collections until the collections either resolve or if they persist beyond 6 weeks, at which time cholecystectomy can be performed safely.
(GRADE 2C, strong agreement).

38
Q

What is the role of cholecystectomy after endoscopic
sphincterotomy in biliary pancreatitis?

A

In patients with biliary pancreatitis who have undergone sphincterotomy and are fit for surgery, cholecystectomy is advised, because ERCP and sphincterotomy prevent recurrence of biliary pancreatitis but not gallstone related gallbladder dis-
ease, i.e. biliary colic and cholecystitis.

(GRADE 2B, strong agreement).